User Profile
Select your user profile

Point-of-care sexually transmitted infection (STI) testing

Liat STI solutions

Targeting high-priority, curable STIs with definitive diagnosis at the point of care


Every day, more than 1 million people acquired an STI worldwide1 and cases are on the rise.2 Even though testing and treatment are available, STIs remain some of the most incorrectly treated medical conditions for a variety of reasons. STI signs and symptoms are often non-specific and overlapping. Multiple STIs can present in one patient, and up to 90% of STI cases can be asymptomatic.3

Most STIs are treatable, but appropriate treatment requires accurate diagnosis. In addition to the high-throughput regular and routine STI testing provided by labs, clinicians and their patients need more access to STI testing on demand and at the point of care. PCR accurate testing can help enable effective treatment, reduce transmission and mitigate the growing concerns of antimicrobial resistance.

It’s time to give patients quick, confident control over their sexual health … where it's needed most. Roche Diagnostics has brought lab-quality PCR testing to the point of care with the cobas® liat system, and has now expanded its offerings to include the cobas® liat CT/NG and cobas® liat CT/NG/MG assays. With this latest innovation in the cobas® liat molecular point-of-care diagnostic portfolio, Roche is excited to launch a new era in STI testing—science-driven solutions made for the point of care.

STI test

Lab-quality STI test results in 20 minutes at the point of care

PCR testing enables patients everywhere to know their sexual health status with confidence. Giving every body the same confidence with fast, accruate results in just 20 minutes.

Benefits of the STI solutions on the cobas® liat system

Quick icon

Quick

 

Results in just 20 minutes to help inform on the appropriate management
Fast results support actionable treatment decisions and reduce the need for patient follow up3,4

 

Confident icon

Confident

 

PCR-accurate to detect and differentiate STIs for effective diagnosis at the POC
Gold standard PCR technology delivers the quality of centralized lab testing at the patient point of care.**  

Control icon

Control

 

Timely POC STI testing with lab-quality control through centralised connectivity
View test results remotely on demand- wherever and whenever needed - with navify® POC Operations.

 

** The cobas liat STI tests (CT/NG and CT/NG/MG) are not available for sale. These tests are pending clearance/approval with Health Authorities.  Information is subject to change based upon these reviews.

Sign up to be among the first to know

Join our mailing list to get the latest about STI solutions on the cobas® liat system and their availability in your region.

 

Form Successfully Submitted!
Thank you for your submission!
text

References:

  1. WHO. STI Fact Sheets. Available from https://www.who.int/news-room/fact-sheets/detail/sexually-transmitted-infections-(stis). Accessed August 2024.
  2. https://www.cdc.gov/std/saw/talktesttreat/default.htm. Accessed 23 March 2024. 
  3. Burkins J, et al. Factors associated with unsuccessful follow-up in patients undertreated for gonorrhea and chlamydia infections. Am J Emerg Med. 2020; 38(4):715-719. 
  4. Rolland C, et al. Who fails to return within 30 days after being tested positive for HIV/STI in a free testing centre? BMC Infect Dis. 2020 Oct 27;20(1):795.